Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Establishing operant conflict tests for the translational study of anxiety in mice

Abstract

Rationale

In conflict-based anxiety tests, rodents decide between actions with simultaneous rewarding and aversive outcomes. In humans, computerised operant conflict tests have identified response choice, latency, and vigour as distinct behavioural components. Animal operant conflict tests for measurement of these components would facilitate translational study.

Objectives

In C57BL/6 mice, two operant conflict tests for measurement of response choice, latency, and vigour were established, and effects of chlordiazepoxide (CDZ) thereon investigated.

Methods

Mice were moderately diet-restricted to increase sucrose reward salience. A 1-lever test required responding under medium-effort reward/threat conditions of variable ratio 2–10 resulting in sucrose at p = 0.7 and footshock at p = 0.3. A 2-lever test mandated a choice between low-effort reward/threat with a fixed-ratio (FR) 2 lever yielding sucrose at p = 0.7 and footshock at p = 0.3 versus high-effort reward/no threat with a FR 20 lever yielding sucrose at p = 1.

Results

In the 1-lever test, CDZ (7.5 or 15 mg/kg i.p.) reduced post-trial pause (response latency) following either sucrose or footshock and reduced inter-response interval (increased response vigour) after footshock. In the 2-lever test, mice favoured the FR2 lever and particularly at post-reward trials. CDZ increased choice of FR2 and FR20 responding after footshock, reduced response latency overall, and increased response vigour at the FR2 lever and after footshock specifically.

Conclusions

Mouse operant conflict tests, especially 2-lever choice, allow for the translational study of distinct anxiety components. CDZ influences each component by ameliorating the impact of both previous punishment and potential future punishment.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Amemori K, Amemori S, Graybiel AM (2015) Motivation and affective judgments differentially recruit neurons in the primate dorsolateral prefrontal and anterior cingulate cortex. J Neurosci 35:1939–1953

  2. Azzinnari D, Sigrist H, Staehli S, Palme R, Hildebrandt T, Leparc G, Hengerer B, Seifritz E, Pryce CR (2014) Mouse social stress induces increased fear conditioning, helplessness and fatigue to physical challenge together with markers of altered immune and dopamine function. Neuropharmacology 85:328–341

  3. Bach DR (2015) Anxiety-like behavioural inhibition is normative under environmental threat-reward correlations. PLoS Comput Biol 11:e1004646

  4. Bach DR, Dayan P (2017) Algorithms for survival: a comparative perspective on emotions. Nat Rev Neurosci 18:311–319

  5. Bach DR, Guitart-Masip M, Packard PA, Miro J, Falip M, Fuentemilla L, Dolan RJ (2014) Human hippocampus arbitrates approach-avoidance conflict. Curr Biol 24:541–547

  6. Bach DR, Korn CW, Vunder J, Bantel A (2018) Effect of valproate and pregabalin on human anxiety-like behaviour in a randomised controlled trial. Transl Psychiatry 8:157

  7. Britton KT, Morgan J, Rivier J, Vale W, Koob GF (1985) Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test. Psychopharmacology 86:170–174

  8. Calhoon GG, Tye KM (2015) Resolving the neural circuits of anxiety. Nat Neurosci 18:1394–1404

  9. Coutinho CB, Cheripko JA, Carbone JJ (1969) Relationship between the duration of anticonvulsant activity of chlordiazepoxide and systemic levels of the parent compound and its major metabolites in mice. Biochem Pharmacol 18:303–316

  10. Dawson GR, Tricklebank MD (1995) Use of the elevated plus maze in the search for novel anxiolytic agents. TiPS 16:33–36

  11. Evenden J, Ross L, Jonak G, Zhou J (2009) A novel operant conflict procedure conflict procedure using incrementing shock intensities to assess the anxiolytic and anxiogeneic effects of drugs. Behav Pharmacol 20:226–236

  12. File SE, Lippa AS, Beer B, Lippa MT (2004) Animal tests of anxiety. In: Current protocols in neuroscience Chapter 8, Unit 8.3

  13. Gray JA, McNaughton N (2000) The neuropsychology of anxiety: an enquiry into the functions of the septo-hippocampal system, 2nd edn. Oxford University Press, Oxford

  14. Gray JA, Davis N, Feldon J, Rawlins NP, Owen SR (1981) Animal models of anxiety. Prog Neuro-Psychopharmacol 5:143–157

  15. Griebel G, Holmes A (2013) 50 years of hurdles and hope in anxiolytic drug discovery. Nat Rev Drug Discov 12:667–687

  16. Ito R, Lee AC (2016) The role of the hippocampus in approach-avoidance conflict decision-making: evidence from rodent and human studies. Behav Brain Res 313:345–357

  17. Jean-Richard-Dit-Bressel P, McNally GP (2015) The role of the basolateral amygdala in punishment. Learn Mem 22:128–137

  18. Jean-Richard-Dit-Bressel P, Killcross S, McNally GP (2018) Behavioral and neurobiological mechanisms of punishment: implications for psychiatric disorders. Neuropsychopharmacology 43:1639–1650

  19. Khemka S, Barnes G, Dolan RJ, Bach DR (2017) Dissecting the function of hippocampal oscillations in a human anxiety model. J Neurosci 37:6869–6876

  20. Kirlic N, Young J, Aupperle RL (2017) Animal to human translational paradigms relevant for approach avoidance conflict decision making. Behav Res Ther 96:14–29

  21. Korn CW, Vunder J, Miro J, Fuentemilla L, Hurlemann R, Bach DR (2017) Amygdala lesions reduce anxiety-like behavior in a human benzodiazepine-sensitive approach-avoidance conflict test. Biol Psychiatry 82:522–531

  22. Lopez-Aumatell R, Guitart-Masip M, Vicens-Costa E, Gimenez-Llort L, Valdar W, Johannesson M, Flint J, Tobena A, Fernandez-Teruel A (2008) Fearfulness in a large N/Nih genetically heterogeneous rat stock: differential profiles of timidity and defensive flight in males and females. Behav Brain Res 188:41–55

  23. Lu SX, Higgins GA, Hodgson RA, Hyde LA, Del Vecchio RA, Guthrie DH, Kazdoba T, McCool MF, Morgan CA, Bercovici A, Ho GD, Tulshian D, Parker EM, Hunter JC, Varty GB (2011) The anxiolytic-like profile of the nociceptin receptor agonist, endo-8-[bis(2-chlorophenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octane-3-carboxami de (SCH 655842): comparison of efficacy and side effects across rodent species. Eur J Pharmacol 661:63–71

  24. Rodgers RJ, Johnson NJ (1995) Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav 52:297–303

  25. Rodgers RJ, Cao BJ, Dalvi A, Holmes A (1997) Animal models of anxiety: an ethological perspective. Braz J Med Biol Res 30:289–304

  26. Shimp KG, Mitchell MR, Beas BS, Bizon JL, Setlow B (2015) Affective and cognitive mechanisms of risky decision making. Neurobiol Learn Mem 117:60–70

  27. Simon NW, Setlow B (2012) Modeling risky decision making in rodents. Methods Mol Biol 829:165–175

  28. Tajima S, Drugowitsch J, Pouget A (2016) Optimal policy for value-based decision-making. Nat Commun 7:12400

  29. Tovote P, Fadok JP, Luthi A (2015) Neuronal circuits for fear and anxiety. Nat Rev Neurosci 16:317–331

  30. Varty GB, Hyde LA, Hodgson RA, Lu SX, McCool MF, Kazdoba TM, Del Vecchio RA, Guthrie DH, Pond AJ, Grzelak ME, Xu X, Korfmacher WA, Tulshian D, Parker EM, Higgins GA (2005) Characterization of the nociceptin receptor (ORL-1) agonist, Ro64-6198, in tests of anxiety across multiple species. Psychopharmacology 182:132–143

  31. Vogel JR, Beer B, Clody DE (1971) A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia 21:1–7

Download references

Acknowledgements

We are grateful to Björn Henz and Alex Osei for animal care. The experiments comply with the current laws of Switzerland.

Funding

This research was funded by the Swiss National Science Foundation (grant 31003A-160147 to CRP).

Author information

Correspondence to Christopher R. Pryce.

Ethics declarations

Conflict of interest

ES is an employee of TSE Systems, Germany. All remaining authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article belongs to a Special Issue on Translational Computational Psychopharmacology

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Oberrauch, S., Sigrist, H., Sautter, E. et al. Establishing operant conflict tests for the translational study of anxiety in mice. Psychopharmacology 236, 2527–2541 (2019). https://doi.org/10.1007/s00213-019-05315-y

Download citation

Keywords

  • Anxiety
  • Reward-aversion conflict
  • Translational test
  • Mouse
  • Operant choice
  • Response latency
  • Response vigour
  • Anxiolytic